Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2019
FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter studyMarie Plante, Nienke van Trommel, Stephanie Lheureux, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2014
Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of diseaseMargaret McCusker, Nicole Basset-Seguin, Reinhard Dummer, et al.
BMC Cancer|October 7, 2011
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?Nicole G Chau, Ana Florescu, Kelvin K Chan, et al.
BMC Urology|June 6, 2018
Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort studyFuraha Kariburyo, Yuexi Wang, I-Ning Elaine Cheng, et al.
American Journal of Cancer Research|May 9, 2018
HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infectionsAnna Manawapat-Klopfer, Lisa Wang, Juliane Haedicke-Jarboui, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2018
Practice-based evidence for the clinical benefit of PET/CT-results of the first oncologic PET/CT registry in GermanyChristina Pfannenberg, Brigitte Gueckel, Lisa Wang, et al.
World Journal of Urology|June 19, 2026
Protocol-driven botulinum toxin injections for pediatric neurogenic bladder: long-term continence and bladder outcomes supporting its role as a minimally invasive alternative to augmentation cystoplastyKay Chua Rivera, Mandy Rickard, Ihtisham Ahmad, et al.
Investigational New Drugs|March 15, 2011
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortiumHelen J Mackay, Heather J Au, Elaine McWhirter, et al.
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
European Journal of Dermatology : EJD|June 25, 2015
The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010Mary Nguyen-Nielsen, Lisa Wang, Lars Pedersen, et al.
Pageof 17